TPWA
GILD icon

Twin Peaks Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,693
Closed -$236K – 1013
2026
Q1 		$236K Buy
1,693
+44
+3% +$6.16K 0.06% 166
2025
Q4 		$250K Buy
+1,649
New +$200K 0.07% 156
2025
Q3 		– Sell
-1,489
Closed -$179K – 938
2025
Q2 		$179K Buy
+1,489
New +$158K 0.06% 165
2025
Q1 		– Sell
-2,480
Closed -$229K – 145
2024
Q4 		$229K Sell
2,480
-405
-14% -$36.5K 0.1% 129
2024
Q3 		$242K Buy
+2,885
New +$220K 0.11% 113
2024
Q2 		– Sell
-3,000
Closed -$220K – 131
2024
Q1 		$220K Sell
3,000
-197
-6% -$15.1K 0.12% 120
2023
Q4 		$259K Buy
+3,197
New +$249K 0.17% 104

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Twin Peaks Wealth Advisors's GILD Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,693 shares — an estimated $236K sold.

Twin Peaks Wealth Advisors first reported a position in GILD in Q4 2023 and held it in 7 quarters. The position peaked at $259K in Q4 2023. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 1,693 Gilead Sciences shares in Q2 2026, an estimated $236K.
  • Twin Peaks Wealth Advisors first reported a position in Gilead Sciences in Q4 2023 and held it in 7 quarters.
  • Twin Peaks Wealth Advisors's Gilead Sciences position peaked at $259K in Q4 2023.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.